Average Co-Inventor Count = 4.44
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (5 from 247 patents)
2. Millennium Pharmaceuticals Limited (4 from 850 patents)
3. Tobira Therapeutics, Inc. (1 from 8 patents)
10 patents:
1. 10517852 - Solid forms of bendamustine hydrochloride
2. 10301287 - Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
3. 10039750 - Solid forms of bendamustine hydrochloride
4. 10017513 - Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoate
5. 10016427 - Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamate
6. 9533955 - Solid forms of bendamustine hydrochloride
7. 9187482 - Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
8. 8883836 - Solid forms of bendamustine hydrochloride
9. 8669279 - Solid forms of bendamustine hydrochloride
10. 8653064 - Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate